| Metric | Q2 2022 | Q1 2022 | Q2 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $819M | — | — | — | — |
| Op. Income | $300M | — | — | — | — |
| Gross Margin | 91.8% | — | — | — | — |
| Net Margin | 30.0% | — | — | — | — |
| EPS (Diluted) | $0.67 | — | — | — | — |
| Free Cash Flow | -$192M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $819M |
| Cost of Revenue | $68M |
| GROSS PROFIT | $751M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $132M |
| SG&A Expenses | $132M |
| Other Expenses | $320M |
| Operating Expenses | $451M |
| Cost & Expenses | $519M |
| OPERATING INCOME | $300M |
| Interest Income | $90M |
| Interest Expense | $68M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $300M |
| Income Tax Expense | $51M |
| Net Income from Continuing Ops | $249M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $245M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $245M |
| D&A | $41M |
| EBIT | $300M |
| EBITDA | $340M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $819M |
| Cost of Revenue | $68M |
| GROSS PROFIT | $751M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $132M |
| SG&A Expenses | $132M |
| Other Expenses | $320M |
| Operating Expenses | $451M |
| Cost & Expenses | $519M |
| OPERATING INCOME | $300M |
| Interest Income | $90M |
| Interest Expense | $68M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $300M |
| Income Tax Expense | $51M |
| Net Income from Continuing Ops | $249M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $245M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $245M |
| D&A | $41M |
| EBIT | $300M |
| EBITDA | $340M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $245M |
| Depreciation & Amortization | $41M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$241M |
| Change in Working Capital | -$232M |
| OPERATING CASH FLOW | -$187M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$5M |
| Net Debt Issuance | $428M |
| Common Stock Repurchased | -$25M |
| Common Dividends Paid | -$118M |
| Other Financing Activities | -$50M |
| NET CASH FROM FINANCING | $240M |
| FREE CASH FLOW | -$192M |
| Net Change in Cash | $19M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.5B |
| Short-Term Investments | $0 |
| Net Receivables | $611M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $2.2B |
| PP&E (Net) | $479M |
| Goodwill | $13M |
| Intangible Assets | $772M |
| Long-Term Investments | $0 |
| Tax Assets | $17M |
| Other Non-Current Assets | $17.9B |
| TOTAL NON-CURRENT ASSETS | $19.2B |
| TOTAL ASSETS | $21.4B |
| Account Payables | $315M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $315M |
| Long-Term Debt | $8.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $6.2B |
| TOTAL NON-CURRENT LIABILITIES | $14.7B |
| TOTAL LIABILITIES | $15.0B |
| Common Stock | $4M |
| Additional Paid-In Capital | $3.0B |
| Retained Earnings | $3.3B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | -$361M |
| TOTAL STOCKHOLDERS' EQUITY | $6.0B |
| Minority Interest | $446M |
| TOTAL EQUITY | $6.4B |
| TOTAL LIABILITIES & EQUITY | $21.4B |
| Total Debt | $8.5B |
| Net Debt | $7.0B |
